$2.70/share and dropping
The share price and lack of any substantial buying interest in NAVB is an absolute joke and a direct reflection on the b.s. that management has been spewing for years now. Where's the "imminent" deal?? Where's the Mastiff p.p. funding? Where's the $5.00/share first traunche? Where are the potential buyers? Where is the P3 trial? What's the status on the FDA meeting?
Whoever thinks these guys are doing a good job needs to check themselves into the clinic for an evaluation. This stock right now is dead money walking. It's despicable.